A study reveals the involvement of the endocannabinoid system in cognitive disorders in mouse models of Down syndrome. The work identifies cannabinoid receptor type-1 (CB1) as a potential treatment target.
A study reveals the involvement of the endocannabinoid system in cognitive disorders in mouse models of Down syndrome. The work identifies cannabinoid receptor type-1 (CB1) as a potential treatment target.